Rethinking
big pharma
The beginning of a year is always a good time to
indulge in a little apocalyptic musing. So how did the
pharmaceutical industry look as 2007 bowed out, and how
should the business model be re-shaped? asks Peter Mansell
Time to bury
the hatchet
While sales and marketing may not have been
the closest of friends in the past, it is time the
two sectors buried the hatchet and worked
together to maximise business outcome,
says Mark Greener
Marketing’s
high flyers
Marketers face testing times in a market and
industry that continues to change focus. The
one constant is PharmaTimes Marketeer of the
Year competition, as Selina McKee reports
The creative touch
Healthcare advertising in general suffers from being too rationally
based, but creativity enables companies to build strong brands and
differentiate where there is no rational difference, finds Peter Mansell
Therapeutic focus:
HIV/AIDS
Since it was first reported 27 years ago,
HIV/AIDS has seldom been out of the
headlines. Michael Day looks at some of the
recent developments in treating this still
growing pandemic
|